A team of scientists from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has identified ...

One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many ...

Akriti Jain, MD, discussed how emerging data on non-ABL1 mutations is reshaping chronic myeloid leukemia management.

The following is a summary of “Efficacy and safety of decitabine combined with arsenic trioxide in elderly high-risk ...

Immunotherapy has revolutionized the way physicians treat patients with cancer. This form of cancer treatment aims to direct the immune system toward the r | Immunology ...

The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the ...

In this procedure, you get chemotherapy or radiation therapy to kill your stem cells ... For example, it's possible it can turn into acute myeloid leukemia (AML). One in three people with MDS ...

Promising Cell Therapy Offers Hope for Relapsed or ... team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the ...

Initial data readout on track for second half of 2025HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ...

Scientists have identified a promising new drug target for acute myeloid leukemia, a deadly blood cancer with a five-year ...